European Medicines Agency, Amsterdam, the Netherlands
The Committee for Advanced Therapies (CAT) is the committee that is responsible for assessing the quality, safety and efficacy of advanced-therapy medicines.
Documents
CAT monthly report of application procedures, guidelines and related documents on advanced therapies: September 2015 meeting
Agenda - CAT agenda of the 17-18 September 2015 meeting
Reference Number: EMA/CAT/629516/2015Summary:
In accordance with the Agency’s health and safety policy, delegates are to be briefed on health, safety and emergency information and procedures prior to the start of the meeting.